GET DAILY SIGNALSCognizant (CTSH) Delivers Margin Expansion in Q3 Despite Narrowed Growth Outlook
Key Takeaways
- Revenue reached $5.664 billion in the third quarter of 2026, up 4.6% year over year, or 4.8% in constant currency.
- GAAP diluted earnings per share (EPS) rose to $1.39 from $0.56 a year earlier, while adjusted diluted EPS grew 7% to $1.49.
- Adjusted operating margin expanded 30 basis points to 16.3%, the company's highest level in four years and its seventh consecutive quarter of year-over-year expansion.
- Financial Services revenue climbed 12.0% year over year, marking the segment's third straight quarter of double-digit growth.
- Full-year 2026 constant-currency revenue growth guidance was trimmed to a range of 4.0% to 4.4%, from a prior 4% to 5.5%.
- Trailing 12-month bookings rose 4% to $28.7 billion, though third-quarter bookings declined 7% year over year.
- For deeper detail on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages covering each of these areas.
- Discover additional trade ideas and market opportunities by exploring Trending AI Robots.
Earnings Context and Why It Matters
Cognizant Technology Solutions reported its third quarter of 2026 results on October 29, 2026. The update carried particular weight because it showed whether the company's AI Builder strategy could turn rising artificial intelligence demand into lasting revenue and profit gains amid uneven client spending. Financial Services showed continued strength, while Health Sciences and Products & Resources faced some pressure from funding caution and tighter discretionary budgets. I was also interested to see whether the multi-quarter margin improvement could hold even as management pointed to softer demand in the fourth quarter, especially in healthcare and consumer areas. This made the release an important signal on enterprise technology services spending overall.
The Reported Numbers
Cognizant posted third-quarter 2026 revenue of $5.664 billion, up 4.6% year over year and 4.8% in constant currency, which aligned closely with estimates around $5.65 billion. GAAP net income came in at $627 million versus $274 million a year earlier, when a one-time tax charge had weighed on results. GAAP diluted EPS reached $1.39 from $0.56 in the prior-year quarter, and adjusted diluted EPS rose 7% to $1.49. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
GAAP operating margin was 15.4%, down 60 basis points year over year, yet adjusted operating margin improved 30 basis points to 16.3%, the highest level in four years. Financial Services revenue grew 12.0% to $1.767 billion, and Communications, Media & Technology increased 10.5% to $939 million with help from acquisitions. Health Sciences slipped 1.1% to $1.587 billion, and Products & Resources declined 0.9% to $1.371 billion. Trailing 12-month bookings reached $28.7 billion, up 4%, for a book-to-bill ratio near 1.3x, although quarterly bookings fell 7%.
For the full year 2026, management narrowed constant-currency revenue growth guidance to 4.0% to 4.4%, pointing to revenue between $22.05 billion and $22.14 billion, and set adjusted diluted EPS guidance at $5.72 to $5.79. Fourth-quarter revenue guidance of $5.49 billion to $5.57 billion came in below consensus estimates near $5.65 billion.
Market Reaction and Investor Sentiment
Investor reaction to the results balances improving profitability against a more cautious near-term outlook. The seventh straight quarter of adjusted operating margin expansion and another period of double-digit growth in Financial Services highlight the effectiveness of the AI-led approach and cost discipline. At the same time, the cut to full-year revenue growth guidance, tied to weaker discretionary spending expected in the fourth quarter, shows that macro uncertainty is starting to affect certain client segments. The below-consensus fourth-quarter revenue view suggests the market is weighing strong execution and margin progress against the possibility of slower near-term growth.
Forward Outlook and Key Factors to Monitor
Several elements will influence Cognizant's path ahead. The staying power of Financial Services growth stands out, given three consecutive quarters of double-digit gains. Investors will track whether large-deal ramps continue to translate into revenue and whether the 60% mix of new versus expansion bookings keeps momentum going despite the 7% year-over-year drop in quarterly bookings.
Margin trends remain a key focus. Adjusted operating margin hit a four-year high, and management lowered projected Project Leap restructuring costs to a range of $180 million to $250 million. Maintaining this expansion while funding AI talent, platforms, and partnerships will draw attention, especially as fixed-price and transaction-based work grows as a portion of revenue.
The demand picture also merits watching. Management noted macro uncertainty pressuring discretionary spending in healthcare and consumer-facing sectors for the fourth quarter. Any signs of stabilization or further softening there, along with progress on initiatives such as the Google Cloud Gemini partnership and the DyFlex Solutions acquisition, could shape how investors view the narrowed full-year guidance.
AI Tools in My Research Workflow
When evaluating quarterly results like these, I find it helpful to cross-check patterns and peer comparisons with Tickeron’s AI Screener. The platform lets me quickly filter for technical signals, fundamentals, and industry trends, which adds useful context to the earnings data without replacing deeper fundamental work.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CTSH in upward trend: 10-day moving average moved above 50-day moving average on October 16, 2026
The 10-day moving average for CTSH crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CTSH as a result. In 44 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for CTSH just turned positive on October 12, 2026. Looking at past instances where CTSH's MACD turned positive, the stock continued to rise in 21 of 40 cases over the following month. The odds of a continued upward trend are 52%.
CTSH moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for CTSH moved above the 200-day moving average on October 12, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +8.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTSH advanced for three days, in 175 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
Bearish Trend Analysis
The 10-day RSI Indicator for CTSH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 17 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 60 cases where CTSH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
CTSH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CTSH entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CTSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.067) is normal, around the industry mean (2.688). P/E Ratio (14.179) is within average values for comparable stocks, (16.241). Projected Growth (PEG Ratio) (0.827) is also within normal values, averaging (2.284). Dividend Yield (0.020) settles around the average of (0.133) among similar stocks. P/S Ratio (1.367) is also within normal values, averaging (139.965).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of information technology services
Industry InformationTechnologyServices
Advertisement